Latest Manufacturing News

European Metals Holdings has raised A$3.46 million through a discounted placement to fund the next phase of its Cinovec Lithium Project, a key European battery-grade lithium source. The company is advancing project financing and strategic partnerships following a positive Definitive Feasibility Study.

Pro-Pac Packaging Group’s Australian and New Zealand operations have been sold to Knoxcorp subsidiaries, while the Perfection Packaging unit is set to shut down by February 2026.

Australian Dairy Nutritionals reported a 152% surge in nutritional powder sales despite regulatory hurdles in Vietnam, while expanding its Future brand footprint across China.

Metal Powder Works reported a stellar December quarter with a threefold increase in CP-Ti orders, expansion into precious metals, and strategic contracts that position it strongly in defence and advanced manufacturing markets.

Sovereign Metals has recovered a heavy rare earth monazite concentrate from its Kasiya project tailings, revealing concentrations of critical elements that surpass those of the world’s largest producers. This discovery could add a lucrative by-product stream at minimal cost, enhancing Kasiya’s strategic value amid tightening global supply chains.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

St George Mining has extended its strategic alliance with US rare earths processor REalloys to finalise potential offtake agreements for high-grade rare earths from the Araxá Project in Brazil. This move aligns with US efforts to build independent rare earth supply chains critical for defence and green technologies.

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

Audeara Ltd reported a strong Q2 FY26 with revenues up 274% year-on-year, securing key regulatory approval in China and expanding its global licensing footprint.

Firebrick Pharma has introduced its Nasodine Throat Spray in Singapore, marking its first international product launch and setting the stage for further global rollouts in 2026.